Insider Trading & Ownership of James M. Daly

Location: Wilmington, DE
Summary: The estimated net worth of James M. Daly is at least $2,044,002 dollars as of 12 Nov 2025. James M. Daly is the Director of HALOZYME THERAPEUTICS, INC. and owns shares of HALOZYME THERAPEUTICS, INC. (HALO) stock worth about $895.8K. James M. Daly is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $877.2K. James M. Daly is the Director of ACADIA PHARMACEUTICALS INC and owns shares of ACADIA PHARMACEUTICALS INC (ACAD) stock worth about $249.4K. James M. Daly is the Director of BELLICUM PHARMACEUTICALS, INC and owns shares of BELLICUM PHARMACEUTICALS, INC stock worth about $21.6K.
Signature: /s/ Jennifer J. Rhodes, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when James M. Daly files a new Insider Trading report.

Ownership of James M. Daly

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
HALO	HALOZYME THERAPEUTICS, INC.	Director	$895,824			11 Aug 2023
MDGL	MADRIGAL PHARMACEUTICALS, INC.	Director	$877,181	-$5,375,126	-86%	20 Jun 2025
ACAD	ACADIA PHARMACEUTICALS INC	Director	$249,397	-$670,983	-73%	10 Nov 2025
BLCM	BELLICUM PHARMACEUTICALS, INC	Director	$21,600			03 Jan 2023
CYTK	CYTOKINETICS INC	Director				19 Aug 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.